NBC Securities’s OnKure Therapeutics OKUR Stock Holding History

NBC Securities’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32	Closed	-$2K	–	2243
2023 Q3	$2K	Buy	+32	New	+$2.18K	﹤0.01%	2042

Other funds holding OKUR

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

NBC Securities's OKUR Position: Q4 2023 in Review

NBC Securities sold out of OnKure Therapeutics (OKUR) in Q4 2023, closing a stake of 32 shares — an estimated $2K sold.

NBC Securities first reported a position in OKUR in Q3 2023 and held it in 1 quarter. The position peaked at $2K in Q3 2023. 68 funds tracked by Wall St. Rank hold OKUR as of Q4 2023.

NBC Securities reported no remaining OnKure Therapeutics position as of Q4 2023 after selling out during the quarter.
NBC Securities sold 32 OnKure Therapeutics shares in Q4 2023, an estimated $2K.
NBC Securities first reported a position in OnKure Therapeutics in Q3 2023 and held it in 1 quarter.
NBC Securities's OnKure Therapeutics position peaked at $2K in Q3 2023.
68 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2023.

Based on NBC Securities's 13F filing for Q4 2023, filed 7 Feb 2024.